Jiangsu Hansoh Pharma Now Said to Plan $3 Billion IPO

According to The Wall Street Journal, Jiangsu Hansoh Pharma is planning to raise over $3 billion in an IPO on the Hong Kong market, which would be record amount for a pharma IPO in Hong Kong. One month ago, it was reported that Hansoh would seek $1.5 billion in an initial offering, implying that the reports are partly rumor. The company may complete a filing for the transaction as early as March, which will shed more light on Hansoh and its IPO. The actual transaction is scheduled for Q3 of this year More details.... Share this with colleagues: // //